89 structural-engineering-"https:"-"https:"-"https:"-"https:"-"https:"-"UCL"-"UCL" positions at Nature Careers in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
postdoctoral researcher position in the group of Professor Jörg Vogel to investigate jumbo phage molecular biology and advance the application of programmable ASO technology as a tool to dissect a phage’s
-
Karlsruhe Institute of Technology (KIT) – The Research University in the Helmholtz Association creates and imparts knowledge for the society and the environment. It is our goal to make significant
-
required: FELASA B and experience coordinating animal experiments Experience with VR-based annotation tools and 3D proofreading MSc or PhD in life sciences, biomedical engineering, optical physics, or a
-
natural and AI-designed protein domains, along with an engineered fusogenic protein. The technology has been recognized with the m4 Award, the GO-Bio next program, and is currently under revision in a top
-
learn about state-of-the-art and emerging AI methods for clinical applications Your profile An excellent master's degree or a PhD in computer science, software engineering, data science, physics
-
experiments Experience with VR-based annotation tools and 3D proofreading MSc or PhD in life sciences, biomedical engineering, optical physics, or a related field Excellent communication skills in scientific
-
systems. We are also running a sequencing facility and conduct translational studies using human samples or genetically engineered model organisms. Multidisciplinary teams of cancer biologists, mouse
-
to balance structured planning with solution-oriented flexibility Confident use of M365 applications (Teams, Excel, PowerPoint) and openness to using AI tools for efficiency Very good command of written and
-
research by developing and combining enabling technologies. Our major research fields are AI-based organ mapping, Tissue engineering and Precision medicine in cancer treatments. Sophisticated technologies
-
protein domains, along with an engineered fusogenic protein. The technology has been recognized with the m4 Award, the GO-Bio next program, and is currently under revision in a top-tier journal (preprint